Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley E Aaroe

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Oncology Reports|March 29, 2019
Central Nervous System Involvement of Natural Killer and T Cell NeoplasmsAshley E Aaroe, Kathryn S Nevel
Current Oncology (Toronto, Ont.)|June 27, 2023
Neurologic Complications of Cancer ImmunotherapyAseel N Alsalem, Leslie A Scarffe, Hannah R Briemberg, et al.
The American Journal of Medicine|January 14, 2026
Fungal Derived Supplements in Integrative OncologyCaroline Mohammed, Ashley E Aaroe, Greg Buchold, et al.
Annals of Neurology|August 30, 2019
Associations between cerebrovascular risk factors and parkinson diseaseBenjamin R Kummer, Iván Diaz, Xian Wu, et al.
Advances in Radiation Oncology|January 27, 2025
Early Outcomes from Proton Craniospinal Irradiation for Leptomeningeal Metastasis From Solid TumorsKeng Lam, Lewis F Nasr, Clark R Andersen, et al.
Neuro-Oncology Practice|July 15, 2024
Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control studyTimothy A Gregory, Stephanie R Knight, Ashley E Aaroe, et al.
Frontiers in Immunology|September 9, 2024
Toxicity in the era of immune checkpoint inhibitor therapySynat Keam, Naimah Turner, Fernanda G Kugeratski, et al.
Neuro-Oncology|July 12, 2025
RANO seizure working group-Tumor Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practiceEdward K Avila, Anne S Reiner, Terri S Armstrong, et al.
Journal of Neuro-Oncology|November 5, 2025
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapyDebra Nana Yeboa, Benjamin T Whitfield, Ruitao Lin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Oncology Reports|March 29, 2019
Central Nervous System Involvement of Natural Killer and T Cell NeoplasmsAshley E Aaroe, Kathryn S Nevel
Current Oncology (Toronto, Ont.)|June 27, 2023
Neurologic Complications of Cancer ImmunotherapyAseel N Alsalem, Leslie A Scarffe, Hannah R Briemberg, et al.
The American Journal of Medicine|January 14, 2026
Fungal Derived Supplements in Integrative OncologyCaroline Mohammed, Ashley E Aaroe, Greg Buchold, et al.
Annals of Neurology|August 30, 2019
Associations between cerebrovascular risk factors and parkinson diseaseBenjamin R Kummer, Iván Diaz, Xian Wu, et al.
Advances in Radiation Oncology|January 27, 2025
Early Outcomes from Proton Craniospinal Irradiation for Leptomeningeal Metastasis From Solid TumorsKeng Lam, Lewis F Nasr, Clark R Andersen, et al.
Neuro-Oncology Practice|July 15, 2024
Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control studyTimothy A Gregory, Stephanie R Knight, Ashley E Aaroe, et al.
Frontiers in Immunology|September 9, 2024
Toxicity in the era of immune checkpoint inhibitor therapySynat Keam, Naimah Turner, Fernanda G Kugeratski, et al.
Neuro-Oncology|July 12, 2025
RANO seizure working group-Tumor Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practiceEdward K Avila, Anne S Reiner, Terri S Armstrong, et al.
Journal of Neuro-Oncology|November 5, 2025
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapyDebra Nana Yeboa, Benjamin T Whitfield, Ruitao Lin, et al.
Pageof 1